Sudeep Pharma informs about resignation of SMP

05 Feb 2026 Evaluate

Pursuant to the Regulation 30 of the of the Securities and Exchange Board of India (‘SEBI’) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Sudeep Pharma has informed that John Garcia (Vice President - Sales & Supply Chain) of Sudeep Pharma USA Inc, designated as SMP, vide his letter dated 4th February 2026 has tendered his resignation with effect from the close of business hours on 6th February, 2026. The requisite disclosure as required as per the requirement of Regulation 30 read with clause 7C of Part A of Schedule III of the Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 enclosed as AnnexureA. A copy of the said resignation letter is enclosed as Annexure-B. The above information is also being made available at the Company’s website at https://www.sudeeppharma.com/. 

The above information is a part of company’s filings submitted to BSE. 

Sudeep Pharma Share Price

665.30 -5.90 (-0.88%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.45
Dr. Reddys Lab 1280.30
Cipla 1341.45
Zydus Lifesciences 901.00
Lupin 2219.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×